Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velmanase Alfa in Pediatric Alpha-Mannosidosis (< 6 Years)
NCT02998879Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2016
- Primary completion
- Jul 2020
- Modality
- Replacement Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of velmanase alfa in alpha-mannosidosis, sponsored by Chiesi Farmaceutici S.p.A.. Started Dec 2016; status: completed.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on NCT02998879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998879.